Studies Conducted at University of Oklahoma Health Sciences Center on Gene Therapy Recently Published (Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice).
In: Gene Therapy Weekly, 2023-03-17, S. 2531-2531
serialPeriodical
Zugriff:
Keywords: Bioengineering; Biotechnology; Drugs and Therapies; Gene Therapy; Health and Medicine; Therapeutics; Therapy EN Bioengineering Biotechnology Drugs and Therapies Gene Therapy Health and Medicine Therapeutics Therapy 2531 2531 1 03/23/23 20230317 NES 230317 2023 MAR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Investigators publish new report on gene therapy. Bioengineering, Biotechnology, Drugs and Therapies, Gene Therapy, Health and Medicine, Therapeutics, Therapy. [Extracted from the article]
Copyright of Gene Therapy Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Studies Conducted at University of Oklahoma Health Sciences Center on Gene Therapy Recently Published (Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice).
|
---|---|
Zeitschrift: | Gene Therapy Weekly, 2023-03-17, S. 2531-2531 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1078-2842 (print) |
Schlagwort: |
|
Sonstiges: |
|